XORTX Therapeutics Inc. — Form D
XORTX Therapeutics Inc. of Calgary, A0, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-31. The offering totals $1.8M. Industry: Other.
Offering
- Filed: 2024-10-31
- Form: D
- Accession: 0001729214-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $1.8M
- Remaining: $1.8M
- Investors: 1
- Date of first sale: 2024-10-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-528293
Issuer
- Name: XORTX Therapeutics Inc.
- CIK: 0001729214
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 3710 - 33rd Street NW, Calgary, A0, T2L 2M1
- Phone: 403-455-7727
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Allen Davidoff | Director | Calgary, A0 |
| William Farley | Director | Calgary, A0 |
| Anthony J Giovinazzo | Director | Calgary, A0 |
| Abigail J Jenkins | Director | Calgary, A0 |
| Raymond J Pratt | Director | Calgary, A0 |
| Patrick J Treanor | Director | Calgary, A0 |
| Paul J Van Damme | Director | Calgary, A0 |
| Allen Davidoff | Executive Officer | Calgary, A0 |
| Stacy Evans | Executive Officer | Calgary, A0 |
| James Fairbairn | Executive Officer | Calgary, A0 |
| Stephen Haworth | Executive Officer | Calgary, A0 |
| JOHN MEEKISON | Executive Officer | Vancouver, A1 |
| Alan Moore | Director | Sheridan, WY |
| Bruce Rowlands | Director | Vancouver, A1 |
Other filings by this issuer (1)
More